Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Hendriks, L.E.; Kerr, K.M.; Menis, J.; Mok, T.S.; Nestle, U.; Passaro, A.; Peters, S.; Planchard, D.; Smit, E.F.; Solomon, B.J.; Veronesi, G.; Reck, M.

doi:10.1016/j.annonc.2022.12.013

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Details

Request a copy

Serval ID

serval:BIB_0E714965871B

Type

Article: article from journal or magazin.

Collection

Publications

Institution

UNIL/CHUV

Title

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Journal

Annals of oncology

Author(s)

Hendriks L.E., Kerr K.M., Menis J., Mok T.S., Nestle U., Passaro A., Peters S., Planchard D., Smit E.F., Solomon B.J., Veronesi G., Reck M.

Working group(s)

ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

ISSN

1569-8041 (Electronic)

ISSN-L

0923-7534

Publication state

Published

Issued date

04/2023

Peer-reviewed

Oui

Volume

34

Number

4

Pages

358-376

Language

english

Notes

Publication types: Practice Guideline
Publication Status: ppublish

Keywords

Humans, Carcinoma, Non-Small-Cell Lung/diagnosis, Carcinoma, Non-Small-Cell Lung/genetics, Carcinoma, Non-Small-Cell Lung/therapy, Lung Neoplasms/diagnosis, Lung Neoplasms/genetics, Lung Neoplasms/therapy, Follow-Up Studies, ESCAT, ESMO Clinical Practice Guideline (CPG), ESMO-MCBS, immunotherapy, non-oncogene-addicted metastatic non-small-cell lung cancer (mNSCLC), treatment, targeted therapy

OAI-PMH

oai:serval.unil.ch:BIB_0E714965871B

DOI

10.1016/j.annonc.2022.12.013

Pubmed

36669645

Web of science

000982505500001

Open Access

Yes

Create date

31/01/2023 17:35